| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/30/2008 | EP1948798A1 Anti-alpha2 integrin antibodies and their uses |
| 07/30/2008 | EP1948788A1 Method of expanding double negative t cells |
| 07/30/2008 | EP1948659A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948658A1 Pyrrolopyrimidine derivatives as syk inhibitors |
| 07/30/2008 | EP1948167A1 Compositions of phosphodiesterase type iv inhibitors |
| 07/30/2008 | EP1948164A1 Pharmaceutical compositions of muscarinic receptor antagonists |
| 07/30/2008 | EP1948128A2 Substance for restoring normal co-expression and interaction between lox and nrage proteins |
| 07/30/2008 | EP1791535B1 Novel tellurium compounds and their use as immunomodulators |
| 07/30/2008 | EP1565547B1 Probiotic strains, a process for the selection of them, compositions thereof, and their use |
| 07/30/2008 | EP1531817B1 Glycinamide derivatives as raf-kinase inhibitors |
| 07/30/2008 | EP1494752B1 Method of treating biological materials with translating electrical fields and electrode polarity reversal |
| 07/30/2008 | EP1478394B1 Stabilized TNFR-Fc composition comprising arginine |
| 07/30/2008 | EP1423525B1 Recombinant mva capable of expressing structural hcv antigens |
| 07/30/2008 | EP1418881B1 Synergistic antimicrobial ophthalmic preparations containing chlorite and hydrogen peroxide |
| 07/30/2008 | EP1366078B1 Ige receptor antagonists |
| 07/30/2008 | EP1315492B1 Use of substituted pyrazoles for the treatment of allergies |
| 07/30/2008 | EP1281398B1 Dermal compositions containing coenzyme q as the active ingredient |
| 07/30/2008 | EP1254124B1 Dipeptide nitrile cathepsin k inhibitors |
| 07/30/2008 | EP1239876B1 Hcv vaccine compositions |
| 07/30/2008 | EP1144600B1 Akt-3 nucleic acids, polypeptides, and uses thereof |
| 07/30/2008 | EP1025124B1 Low-toxicity human interferon-alpha analogues |
| 07/30/2008 | CN101233154A Stable and soluble antibodies inhibiting TNF alpha |
| 07/30/2008 | CN101233124A Glycolipid derivative and therapeutic agent comprising the same as active ingredient |
| 07/30/2008 | CN101232903A Toxin peptides with extended blood halflife |
| 07/30/2008 | CN101232900A Use of the ides proteinase (from s. pyogenes) for treating autoimmune diseases and graft rejection |
| 07/30/2008 | CN101230103A Human recombinant anti-IgE antibody |
| 07/30/2008 | CN101230095A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230094A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230093A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230092A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230091A Polypeptide organic compound and use thereof in hetero transplantation |
| 07/30/2008 | CN101230012A Extractive separation method of cicadae flower immunological suppression active effective part ISP extracts |
| 07/30/2008 | CN101229371A Use of anti-TNFalpha antibodies and another drug |
| 07/30/2008 | CN101229320A Glutathione ammoniacum compounds and processing method thereof |
| 07/30/2008 | CN101229291A Chinese traditional medicine immunoregulation prescription for treating virus hepatitis and method thereof |
| 07/30/2008 | CN101229286A Compounds of vitamin and plant extract |
| 07/30/2008 | CN101229272A Medicine compounds for increasing immunizing-power, preparing method and applications thereof |
| 07/30/2008 | CN101229175A Medical applications of couple protopanoxadiol derivatives and compound body thereof |
| 07/30/2008 | CN101229174A Antianaphylaxis compound containing epinastine hydrochloride |
| 07/30/2008 | CN101228945A Ginger noodle and producing method thereof |
| 07/30/2008 | CN100406891C 利用EPF受体鉴定结合或调节hDRR活性的化合物以及hDRR的分离 Identification of isolated compounds utilizing EPF receptor binding or regulate the activity and hDRR of hDRR |
| 07/30/2008 | CN100406562C Humanized immunoglobulin reactive with alpha 4 beta 7 integrin |
| 07/30/2008 | CN100406555C Method for preparing dendritic cell for cancer immunotherapy |
| 07/30/2008 | CN100406473C Preparation method and application of Asiatic polysaccharide |
| 07/30/2008 | CN100406459C 3-heteroaryl-3,5-dihydro-4-oxo-4h-pyridazino[4,5-b]indole-1-acetamide derivatives, preparation and use thereof in medicaments |
| 07/30/2008 | CN100406454C Pyrazole compounds useful as protein kinase inhibitors. |
| 07/30/2008 | CN100406448C Pseudopolymorphic forms of z-[2-[4-(bis(4-fluorophenyl)methyl]-1-piperazinyl]ethozy] acetic and dihydrochloride |
| 07/30/2008 | CN100406441C Cyclic amine compounds |
| 07/30/2008 | CN100406439C Pyrrolidine derivatives as metalloprotease inhibitors |
| 07/30/2008 | CN100406437C Amino alcohol derivatives or phosphonic acid derivatives and pharmaceutical compositions containing these |
| 07/30/2008 | CN100406060C Adjuvant composition |
| 07/30/2008 | CN100406057C Amelioration of effects of cigarette smoke |
| 07/30/2008 | CN100406042C Chinese medicine composition for strengthening immunity, beautifying and treating skin disease |
| 07/30/2008 | CN100406025C Pharmacal use of sex steroid antagonist and sex steroid agonist |
| 07/30/2008 | CN100406007C Asthma and allergic inflammation modulators |
| 07/30/2008 | CN100406004C Vaccine composition and method of using same |
| 07/30/2008 | CA2627364A1 Extracellular matrix materials as vaccine adjuvants for diseases associated with infectious pathogens or toxins |
| 07/29/2008 | US7405310 Non-nucleoside reverse transcriptase inhibitors |
| 07/29/2008 | US7405306 3-(2-alkoxycarbonyl-3-indolyl)-3-oxo-propionic acid ester or propionamide intermediates: methyl 3-[6-fluoro-2-(methoxycarbonyl)-1-methyl-1H-indol-3-yl]-3-oxopropanoate; peripheral neuropathy, Parkinson's disease, Alzheimer's disease |
| 07/29/2008 | US7405295 Certain imidazo[1,2-a]pyrazin-8-ylamines and method of inhibition of Bruton's tyrosine kinase by such compounds |
| 07/29/2008 | US7405276 First antigen recognition portion that binds a C3b-like receptor and a second that binds an antigenic molecule present in the circulatory system |
| 07/29/2008 | US7405273 Fusion protein of antigens from parainfluenza virus (PIV) and respiratory syncytial virus (RSV); single recombinant immunogen can protect susceptible individuals against diseases caused by both PIV and RSV |
| 07/29/2008 | US7405225 Substituted 3-amino-thieno[2,3-b]pyridine-2-carboxylic acid amide compounds and processes for preparing and their uses |
| 07/29/2008 | US7405223 Treating allergic and inflammatory conditions |
| 07/29/2008 | US7405211 Therapeutic morpholino-substituted compounds |
| 07/29/2008 | US7405206 Administering by inhalation; antiinflammatory agents, antiallergens; skin disorders; reacting androstane compound with 2-oxofuran compound |
| 07/29/2008 | US7405194 Therapeutic agents and methods of use thereof for the treatment of melanoma |
| 07/29/2008 | US7404953 anti-human interleukin-5 receptor alpha -chain monoclonal antibody; asthma; atopic dermatitis |
| 07/29/2008 | US7404270 Tumor antigen |
| 07/29/2008 | CA2438813C Alkoxycarbonylamino heteroaryl carboxylic acid derivatives as ip antagonists |
| 07/29/2008 | CA2432222C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2432132C Pyrazole compounds useful as protein kinase inhibitors |
| 07/29/2008 | CA2409842C 1,4-diazepan-2,5-dione derivatives and their use as nk-1 receptor antagonists |
| 07/29/2008 | CA2401033C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
| 07/29/2008 | CA2382322C Aminocarbonyl-substituted benzimidazole derivatives, processes for preparing them and their use as pharmaceutical compositions |
| 07/29/2008 | CA2348742C Carbocyclic potassium channel inhibitors |
| 07/29/2008 | CA2337755C Inhibitors of p38 |
| 07/29/2008 | CA2333656C A novel vla-4 inhibitor: omepupa-v |
| 07/29/2008 | CA2261835C Long-acting drugs and pharmaceutical compositions comprising them |
| 07/29/2008 | CA2218702C Fatty acid esters as bioactive compounds |
| 07/29/2008 | CA2218096C New arylglycinamide derivatives, processes for the manufacture thereof and pharmaceutical compositions containing these compounds |
| 07/29/2008 | CA2199809C Synthetic ganglioside derivatives |
| 07/29/2008 | CA2192543C Interleukin-5 specific recombinant antibodies |
| 07/29/2008 | CA2160121C T cell epitopes of the major allergens from dermatophagoides (house dust mite) |
| 07/29/2008 | CA2141842C Novel glycoforms of soluble complement receptor 1 |
| 07/24/2008 | WO2008088047A1 Method for glycosylation of flavonoid |
| 07/24/2008 | WO2008087933A1 NOVEL INDOLE DERIVATIVE HAVING INHIBITORY ACTIVITY ON IϰB KINASE β |
| 07/24/2008 | WO2008087441A2 An influenza prevention and treatment composition |
| 07/24/2008 | WO2008087371A1 New combination for use in the treatment of inflammatory disorders |
| 07/24/2008 | WO2008087219A1 Compositions and methods for regulating t cell activity |
| 07/24/2008 | WO2008087155A1 Use of entacapone in cosmetic, dermatological and pharmaceutical compositions |
| 07/24/2008 | WO2008086612A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086610A1 Hat acetylation promoters and uses of compositions thereof in promoting immunogenicity |
| 07/24/2008 | WO2008086556A1 Method of inducing an immune response |
| 07/24/2008 | WO2008070861A3 Methods and compositions for treating systemic lupus erythematosus |
| 07/24/2008 | WO2008065378A3 Binding members for interleukin-6 |
| 07/24/2008 | WO2008065378A2 Binding members for interleukin-6 |
| 07/24/2008 | WO2008048607A3 Collagen peptides as immune modulators |
| 07/24/2008 | WO2008027338A3 Antagonistic human light-specific human monoclonal antibodies |
| 07/24/2008 | US20080177071 Process for the preparation of 2- (2- (4- (bis (4-flourophenyl) methyl) -pipe razin-1-yl) ethoxy acetic acid derivatives or corresponding salt forms thereof and intermediates therefor |